Myricx Bio Announces Expansion of its Leadership Team to Advance NMTi-ADCs into Clinical Development
Myricx Bio (‘Myricx’), a UK-based biotech company focusing on the discovery and development of a completely novel class of payloads for antibody-drug conjugates (ADCs), is pleased to announce team ...
Ondine Biomedical Inc. (LON: OBI) reports that University Hospital Zurich (USZ) has initiated an independent clinical study evaluating Steriwave®. This marks the first Swiss deployment of Ondine’s ...
CPI has created a ‘Digital Architecture’, a step-by-step strategy and coded blueprint to enable pharmaceutical companies to digitalise every aspect of the manufacturing process. Digitalisation is ...
ELRIG, a not-for-profit, volunteer-led organisation dedicated to the drug discovery community, has appointed Dr Del Trezise as Chair of the Board. In this role, he will lead ELRIG’s mission to foster ...
Vertex Pharmaceuticals (Nasdaq: VRTX) today announced that the European Commission has granted regulatory approval for a label expansion of KAFTRIO® (ivacaftor/tezacaftor/elexacaftor) in a combination ...
Leading contract research company BDD has opened its new 122m² GMP manufacturing facility at BioCity near Glasgow, following a successful inspection by the Medicines and Healthcare products Regulatory ...
CAS, a division of the American Chemical Society specializing in scientific content and knowledge management, and Cleveland Clinic, an academic health system with a global footprint, announced plans ...
Vantage Market Research report examines the Antibody Drug Conjugates (ADCs) market, forecasting trends and dynamics from 2025 ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback